发明名称 Nitric oxide-releasing diazeniumdiolated polyvinylpyrrolidone-based polymers, and compositions, medical devices, and uses thereof
摘要 Disclosed is a nitric oxide-releasing polyvinylpyrrolidone-based polymer derived from N-vinylpyrrolidone monomer and at least one nitric oxide releasing N2O2− group, in which the N2O2− group is attached to a 2 pyrrolidinone group or a group derived therefrom in the N-vinylpyrrolidone monomer, and the polymer is optionally in combination with a substrate. The NO-releasing polymer can be part of a medical device or pharmaceutical composition and is useful for treating a biological disorder, such as healing a wound, restenosis, and/or promoting angiogenesis.
申请公布号 US9540471(B2) 申请公布日期 2017.01.10
申请号 US201314414765 申请日期 2013.07.17
申请人 The United States of America, as represented by the Secretary, Department of Health and Human Services 发明人 Hrabie Joseph A.;Keefer Larry K.
分类号 C08F226/10;A61K31/79 主分类号 C08F226/10
代理机构 Leydig, Voit & Mayer, Ltd. 代理人 Leydig, Voit & Mayer, Ltd.
主权项 1. A nitric oxide-releasing polyvinylpyrrolidone-based polymer comprising at least one monomer unit derived from N-vinylpyrrolidone and at least one monomer unit selected from the group consisting of formula (I) and formula (II) or a composite comprising the polymer in combination with a substrate, wherein R1 is —CH2CH2CR4R5C(O)OR6, R2, R3, R4, and R5 are the same or different and each is H or N2O2M, M is hydrogen ion or a pharmaceutically acceptable cation, and R6 is H, an unsubstituted or substituted C1-12 alkyl, an unsubstituted or substituted C2-8 alkenyl, an unsubstituted or substituted C3-C6 cycloalkyl, a substituted or unsubstituted aryl, or C1-12 trialkylsilyl, provided at least one of R2-5 is N2O2M in formula (I) and formula (II).
地址 Washington DC US